Immunosensors—principles and applications to clinical chemistry
Introduction: Immunosensors are affinity ligand-based biosensor solid-state devices in
which the immunochemical reaction is coupled to a transducer. The fundamental basis of all …
which the immunochemical reaction is coupled to a transducer. The fundamental basis of all …
[HTML][HTML] Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges
Tremendous efforts have been made over the past few decades to discover novel cancer
biomarkers for use in clinical practice. However, a striking discrepancy exists between the effort …
biomarkers for use in clinical practice. However, a striking discrepancy exists between the effort …
Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings
Purpose : Approximately 25% of radical prostatectomies performed for stage T1c disease
show potentially insignificant prostate cancer. We previously reported the use of serum …
show potentially insignificant prostate cancer. We previously reported the use of serum …
Natural history of progression after PSA elevation following radical prostatectomy
Context In men who develop an elevated serum prostate-specific antigen level (PSA) after
having undergone a radical prostatectomy, the natural history of progression to distant …
having undergone a radical prostatectomy, the natural history of progression to distant …
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
HB Carter, JD Pearson, EJ Metter, LJ Brant, DW Chan… - Jama, 1992 - jamanetwork.com
Objective. ——To evaluate longitudinal changes in prostate-specific antigen (PSA) levels in
men with and without prostate disease. Design. —Case-control study of men with and …
men with and without prostate disease. Design. —Case-control study of men with and …
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
Clinical stage, Gleason score and serum prostate specific antigen (PSA) levels are used
separately to predict pathological stage in patients with localized prostate cancer. Because the …
separately to predict pathological stage in patients with localized prostate cancer. Because the …
Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core …
HUPO initiated the Plasma Proteome Project (PPP) in 2002. Its pilot phase has (1) evaluated
advantages and limitations of many depletion, fractionation, and MS technology platforms; (…
advantages and limitations of many depletion, fractionation, and MS technology platforms; (…
Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer
…, J Rosenzweig, YY Wang, DW Chan - Clinical …, 2002 - academic.oup.com
… Daniel W Chan Daniel W Chan … Jinong Li, Zhen Zhang, Jason Rosenzweig, Young Y
Wang, Daniel W Chan, Proteomics and Bioinformatics Approaches for Identification of Serum …
Wang, Daniel W Chan, Proteomics and Bioinformatics Approaches for Identification of Serum …
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Early detection remains the most promising approach to improve long-term survival of
patients with ovarian cancer. In a five-center case-control study, serum proteomic expressions …
patients with ovarian cancer. In a five-center case-control study, serum proteomic expressions …
[HTML][HTML] Integrated proteogenomic characterization of human high-grade serous ovarian cancer
To provide a detailed analysis of the molecular components and underlying mechanisms
associated with ovarian cancer, we performed a comprehensive mass-spectrometry-based …
associated with ovarian cancer, we performed a comprehensive mass-spectrometry-based …